Pathstone Family Office’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$897K Buy
10,337
+7,170
+226% +$648K 0.01% 762
2023
Q2
$325K Buy
+3,167
New +$268K ﹤0.01% 936
2023
Q1
Sell
-13,834
Closed -$769K 1253
2022
Q4
$769K Buy
13,834
+7,282
+111% +$553K 0.01% 907
2022
Q3
$448K Buy
+6,552
New +$415K ﹤0.01% 1119
2021
Q1
Sell
-262
Closed -$14K 769
2020
Q4
$14K Buy
+262
New +$13.6K ﹤0.01% 798
2019
Q1
Sell
-9
Closed 893
2018
Q4
$0 Buy
+9
New +$469 ﹤0.01% 535
2017
Q2
Sell
-8
Closed -$1K 421
2017
Q1
$1K Buy
+8
New +$630 ﹤0.01% 438
2013
Q4
Sell
-95
Closed -$5K 225
2013
Q3
$5K Sell
95
-35
-27% -$1.78K 0.02% 206
2013
Q2
$6K Buy
+130
New +$5.94K 0.01% 265

Other funds holding CAH

Pathstone Family Office's CAH Position: Q3 2023 in Review

Pathstone Family Office increased its Cardinal Health (CAH) stake by 226% in Q3 2023, buying an estimated $648K and bringing the position to 10,337 shares worth $897K. The position accounts for 0.01% of the portfolio, ranked #762.

Pathstone Family Office first reported a position in CAH in Q2 2013 and has held it in 9 quarters since. 948 funds tracked by Wall St. Rank hold CAH as of Q3 2023.

  • Pathstone Family Office held 10,337 shares of Cardinal Health worth $897K as of Q3 2023.
  • Pathstone Family Office bought 7,170 Cardinal Health shares in Q3 2023, an estimated $648K.
  • Cardinal Health made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #762 holding.
  • Pathstone Family Office first reported a position in Cardinal Health in Q2 2013 and has held it in 9 quarters since.
  • 948 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.